Jenny Permuth‐Wey

2.8k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Jenny Permuth‐Wey is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Jenny Permuth‐Wey has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Jenny Permuth‐Wey's work include BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Jenny Permuth‐Wey is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Jenny Permuth‐Wey collaborates with scholars based in United States and Canada. Jenny Permuth‐Wey's co-authors include Tuya Pal, Thomas A. Sellers, Rebecca Sutphen, Alan Cantor, Santo V. Nicosia, James P. LaPolla, Martin A Martino, Katie Wakeley, George D. Wilbanks and Mitchell Hoffman and has published in prestigious journals such as Cancer, Cancer Research and Oncogene.

In The Last Decade

Jenny Permuth‐Wey

10 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

2005 524 citations Tuya Pal, Jenny Permuth‐Wey et al. Cancer profile →

Peers

Countries citing papers authored by Jenny Permuth‐Wey

Since Specialization

Citations

This map shows the geographic impact of Jenny Permuth‐Wey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Permuth‐Wey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Permuth‐Wey more than expected).

Fields of papers citing papers by Jenny Permuth‐Wey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Permuth‐Wey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Permuth‐Wey. The network helps show where Jenny Permuth‐Wey may publish in the future.

Co-authorship network of co-authors of Jenny Permuth‐Wey

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Permuth‐Wey. A scholar is included among the top collaborators of Jenny Permuth‐Wey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Permuth‐Wey. Jenny Permuth‐Wey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer 2013 ·Oncogene ·(unknown), Lili He, Eric J. Richards, Sridevi Challa, Xu Cx, Jenny Permuth‐Wey, Jonathan Lancaster, Domenico Coppola, Thomas A. Sellers, J Y Djeu, Jun Cheng	341
2	Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility 2012 ·Cancer Research ·Ya-Yu Tsai, Álvaro N.A. Monteiro, Catherine M. Phelan, Edwin S. Iversen, Brooke L. Fridley, Y. Ann Chen, Zhihua Chen, Jenny Permuth‐Wey, Heather Jim, Robert A. Vierkant, Julie M. Cunningham, Jill S. Barnholtz‐Sloan, Avery August, Rebecca Sutphen, Steven A. Narod, Harvey A. Risch, Joellen M. Schildkraut, Ellen L. Goode, David Fenstermacher, Thomas A. Sellers	1
3	Sampling Strategies for Tissue Microarrays to Evaluate Biomarkers in Ovarian Cancer 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Jenny Permuth‐Wey, David Boulware, Nikola Valkov, Sandra Livingston, Santo V. Nicosia, Ji‐Hyun Lee, Rebecca Sutphen, Joellen M. Schildkraut, Steven A. Narod, Alex Parker, Domenico Coppola, Thomas A. Sellers, Tuya Pal	11
4	A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer 2008 ·Cancer ·Tuya Pal, Jenny Permuth‐Wey, Thomas A. Sellers	84
5	Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology 2008 ·Clinical Cancer Research ·Tuya Pal, Jenny Permuth‐Wey, Ambuj Kumar, Thomas A. Sellers	110
6	Development of a lay brochure introducing genetic testing and counseling for BRCA1/2 in women of color 2007 ·Cancer Epidemiology and Prevention Biomarkers ·Desiree Rivers, Susan T. Vadaparampil, (unknown), (unknown), Jenny Permuth‐Wey, Tuya Pal	1
7	Improved survival in BRCA2 carriers with ovarian cancer 2006 ·Familial Cancer ·Tuya Pal, Jenny Permuth‐Wey, Rachna Kapoor, Alan Cantor, Rebecca Sutphen	52
8	BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases breakdown → 2005 ·Cancer ·Tuya Pal, Jenny Permuth‐Wey, (unknown), Jeffrey P. Krischer, James V. Fiorica, Hector Arango, James P. LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley, George D. Wilbanks, Santo V. Nicosia, Alan Cantor, Rebecca Sutphen	524
9	BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients 2004 ·Cancer Epidemiology Biomarkers & Prevention ·Tuya Pal, Jenny Permuth‐Wey, (unknown), Rebecca Sutphen	36
10	BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. 2004 ·PubMed ·Tuya Pal, Jenny Permuth‐Wey, (unknown), Rebecca Sutphen	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact